Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Worth every penny
Unlike most peptides on the FDA's review schedule, GHK-Cu (copper peptide) has a split regulatory path: non-injectable routes are being removed from Category 1, while injectable routes are being removed from Category 2 and both are heading to Pharmacy Compounding Advisory Committee (PCAC) review before February 2027
Not all pharmacies do, and this testing is the only way to verify that the labeled concentration matches what is actually in your vial
Lewanda AF, Gallegos MF, Summar M
US$ 26.32
&srotate=0)
US$ 25.03
US$ 25.55
